Navigation Links
Health Robotics South East Asia Wins two key Cancer Therapy Outsourcing Projects in Malaysia and Thailand
Date:5/31/2010

BOZEN, Sud-Tirol, Italy, May 31, 2010 /PRNewswire/ -- Health Robotics today announced that its joint venture Health Robotics South East Asia Ltd. scored two strategic wins by reaching agreements on two separate government-sponsored projects to deliver CytoCare-made accurate and sterile oncology patient doses in Kuala Lumpur and Bangkok, respectively. Health Robotics' CytoCare is the first and only robot in the world proven to automatically compound and dispense oncology intravenous therapy treatments to patients.

Health Robotics South East Asia announced the opening of two outsourcing centers within close distance to Kuala Lumpur General Hospital in 4Q2010 and the National Cancer Institute Thailand in 1Q 2011, respectively. These two key projects consolidate the leadership position of Health Robotics SEA within Private Finance Initiatives (PFIs) in the region [PFIs are initiatives that, in addition to products and services, provide financial support under public-private partnerships]. The contracted plan for the outsourcing centers already includes the purchase of CytoCare and i.v.STATION robotic devices, and a state-of-the-art logistics system already in place for other medical supplies. These assets will be complemented by Health Robotics SEA's future selection of strategic partners for compounding services, IV consumables, and both generic and proprietary oncology medications to be used in the 2 centers, all currently in the process of vendor selection.

"I'm very pleased that our South East Asia joint venture's chemotherapy outsourcing and PFI strategies are beginning to produce outstanding results. I look forward to their future expansion to all government-owned hospitals in Malaysia and Thailand, as well as quick geographical expansion into other countries in the region, such as Singapore, India and Vietnam. We are firm believers that the 'pay-per-dose' outsourcing business model is an excellent fit for our best-in-class technology and workflow processes in the region, offering a win-win scenario to capital-starved public hospitals. I have personally witnessed in Turkey the excellent results of a similar 'pay-per-dose' outsourcing model in combination with a government-sponsored partnership, resulting in orders for 24 CytoCare robots within the past 2 years from our Turkish strategic partner Rivosem. We plan similar 'pay-per-dose' outsourcing business models wherever applicable, including selected countries in Western Europe," stated Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding, powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff.

For more company information including a corporate video, please visit http://www.health-robotics.com/en/about-health-robotics/. For additional information, please contact:

    Health Robotics S.r.l.
    Claudia Flaim, Marketing Coordinator
    Phone: +39-0471-200-372
    flaim@health-robotics.com

    Health Robotics South East Asia Ltd.
    Rejeni Kanthen, Senior Vice President
    Phone: +60-321-648-223
    kanthen@drmgroup.com.my



'/>"/>
SOURCE Health Robotics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h)
2. Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish
3. Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHPs Summer Meeting, Tampa, June 6-8, 2010
4. Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team
5. InterMune to Present at 2010 Citi Health Care Conference
6. Healthcare Data Solutions Announces New Healthcare eMarketing Webinar
7. Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramals Healthcare Solutions Business
8. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Amylin Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference
10. ASU Nursing and Health Launches Regulatory Science and Health Safety Masters Program
11. The MedZilla Report for May 2010 - U.S. Unemployment Rate Edges Higher, But Healthcare Still Adds Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... ... cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure ... was performed on a 55-year-old practicing female physician suffering from degenerative disc disease ...
(Date:2/16/2017)... BOSTON , Feb. 16, 2017 /PRNewswire/ ... for rare genetic deficiencies that result in ... of a $41 million mezzanine round of ... Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, ... an undisclosed public healthcare investment fund. Rhythm ...
Breaking Biology Technology:
(Date:1/19/2017)... India , January 19, 2017 According to a ... Opportunities and Forecast, 2014 - 2022," the global biometric sensor market is expected ... 2016 to 2022. In 2015, Asia-Pacific dominated the global ... and private sectors. Continue Reading ... ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
Breaking Biology News(10 mins):